✦ LIBER ✦

Clinical drug resistance: The role of factors other than P-glycoprotein

✍ Scribed by Stanley B. Kaye

Book ID: 117016980
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 749 KB
Volume: 99
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(99)80285-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of P-glycoprotein in drug resis

The role of P-glycoprotein in drug resistance in multiple myeloma

✍ Abraham, Joseph; Salama, Noha N.; Azab, Abdel Kareem 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 217 KB

Encyclopedia of Stress || Multi Drug Res

Encyclopedia of Stress || Multi Drug Resistance P Glycoprotein and other Transporters

✍ de Lange, E.C.M. 📂 Article 📅 2007 🏛 Elsevier ⚖ 114 KB

Mechanisms of multidrug resistance in hu

Mechanisms of multidrug resistance in human tumor cells. The roles of P-glycoprotein, DNA topoisomerase II, and other factors

✍ Beck, William T. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 736 KB

Drug resistance and the P-glycoprotein h

Drug resistance and the P-glycoprotein homologues of Plasmodium falciparum

✍ Alan F. Cowman; Steve Karcz 📂 Article 📅 1993 🏛 Elsevier Science ⚖ 409 KB

Multidrug resistance and the role of P-g

Multidrug resistance and the role of P-glycoprotein knockout mice

✍ A.H Schinkel; C.A.A.M Mol; E Wagenaar; L van Deemter; J.J.M Smit; P Borst 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 510 KB

Verapamil suppresses the emergence of P-

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance

✍ Bernard W. Futscher; Nils E. Foley; Mary C. Gleason-Guzman; Paul S. Meltzer; Dan 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 830 KB

Selection protocols were designed to determine whether non-cytotoxic chemomodifiers can influence the evolution of the drug-resistant phenotype. To this end, the human multiple myeloma cell line RPMl8226 (8226/S) was selected with either doxorubicin, verapamil or doxorubicin plus verapamil. Using th